04/25/2024
4:24 PM | Structure Therapeutics (Filer)
| Form ARS | |
04/19/2024
1:13 PM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:34 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:37 PM | Structure Therapeutics (Issuer)
Yoon Jun (Reporting)
| Form 4/A | |
03/20/2024
6:39 PM | Ma Yingli (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:41 PM | Bach Mark Allen (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:42 PM | Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
|
03/19/2024
3:36 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:52 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:19 PM | Structure Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2024
8:19 AM | Structure Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
7:43 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
10:11 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:07 AM | Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:45 AM | Deep Track Capital, LP (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
6:59 AM | FIL Ltd (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024
10:01 AM | Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
12/27/2023
9:49 AM | Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
9:49 AM | FMR LLC (Reporting)
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:36 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
12/18/2023
7:28 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
10:04 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
11:15 PM | Structure Therapeutics (Filer)
| Form EFFECT | |
11/17/2023
4:25 PM | Structure Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/17/2023
3:51 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
11/17/2023
3:55 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/16/2023
4:13 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
10/23/2023
2:55 PM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
3:00 PM | FMR LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
10/12/2023
7:55 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
11:01 AM | FIL Ltd (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
09/29/2023
6:50 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
6:38 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
4:37 PM | Structure Therapeutics (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
4:29 PM | LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/04/2023
4:34 PM | LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
3:30 PM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
7:00 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
4:00 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
